A malaria vaccine just got 40% cheaper — and that could protect up to a million more children

For a mother in a malaria hotspot, the price of a vaccine can decide whether her child is protected. UNICEF and Gavi have agreed to cut the price of the Mosqivac (RTS,S/AS01) vaccine by about 40%, to €5.50 (about $6.16) per dose from early 2027. The deal is expected to save about $50 million between 2027 and 2029 — money that could fully protect up to a million more children with the recommended four doses, as production moves to Bharat Biotech in India.

SDG 3 · Good health and well-being — Mechanism: market force